Comparing health e-coaching to standard care for overweight young adults
Randomized Controlled Trial PRALIMAP-CINeCO: Comparison of Health E-coaching Versus Referral to the Usual Care System for Overweight and Obese Young Adults
This study is testing if health e-coaching helps overweight young adults make better health changes compared to regular care they usually receive.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 384 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Nancy) |
| Trial ID | NCT05399407 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of health e-coaching compared to traditional referral to the usual care system for young adults who are overweight or obese. Participants include those from the PRALIMAP-INES trial and student volunteers from the University of Lorraine. The study aims to determine which approach is more acceptable and beneficial for promoting health changes. Participants will be randomly assigned to either the e-coaching group or the control group receiving standard care.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-30 with a BMI greater than 25 kg/m² or a high percentage of body fat who are not currently receiving medical care for their condition.
Not a fit: Patients who are under medical care for their weight issues or do not meet the BMI or body fat criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective and accessible method for managing overweight and obesity in young adults.
How similar studies have performed: Other studies have shown promising results with e-coaching interventions for weight management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Among the young adults who agreed to participate in follow-up visit (T3) in the PRALIMAP-CINeCO trial (Part 1), the inclusion criteria for the inclusion criteria for the proposed research are as follows: * Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data * Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T3) * Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (Q3) * Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation * Agree to participate in the follow-up * Accepting the health e-coaching/orientation to routine care * Affiliated to a social security system or beneficiary of such a system * Reside in France Among the students who agreed to participate, through the Student Health Service of the University of Lorraine, the inclusion criteria for the proposed research are as follows: * Person having received complete information on the organization of the research and not and who did not object to their participation and to the use of their data to participate and to use their data * Have agreed to complete the pre-test questionnaire prior to/at the follow-up visit (T0) * Have agreed to the anthropometric measurements without invasive intervention performed at the follow-up visit (T0) * Have a BMI greater than 25kg/m² (Cole et al. 2000) or a percentage of body fat mass greater than or equal to 20% for men and greater than or equal to 33% for women, depending on age and greater than or equal to 33% for women and not receiving medical medical care for this situation * Agree to participate in the follow-up * Accepting the health e-coaching/orientation to routine care * Affiliated to a social security system or beneficiary of such a system * Reside in France * Be of legal age (18 years or older) * Be a student at the Université de Lorraine Exclusion Criteria: If the follow-up visit n°3 (T3) during the PRALIMAP-CINeCO trial (1st part) or the inclusion visit (T0 for University of Lorraine students), was completed, the non-inclusion criteria for the referral of young adults young adults (health e-coaching/current care) are as follows: * Do not feel the need for coaching * Be already being treated for overweight by a health professional specializing in the treatment of specialized in the treatment of overweight and obesity or a specialized specialized medical structure/service * Do not agree to participate in the continuation of PRALIMAP-CINeCO * Major person under a legal protection measure (guardianship, curatorship, safeguard of justice) * Persons deprived of liberty by a judicial or administrative decision administrative decision Persons under psychiatric care in accordance with Articles L. 3212-1 and L. 3213-1 of the Public Health Code
Where this trial is running
Nancy
- CHRU de Nancy — Nancy, France (Recruiting)
Study contacts
- Study coordinator: Yacoubou OMOROU
- Email: Y.OMOROU@chru-nancy.fr
- Phone: 0383859303
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.